What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Internal medicine
His scientific interests lie mostly in Immunology, Dendritic cell, T cell, Transplantation and Immune system.
His Immunology research includes elements of Cytotoxic T cell and Molecular biology.
His Dendritic cell research incorporates elements of Cytokine, Progenitor cell, Cell biology, Major histocompatibility complex and Antigen presentation.
The T cell study combines topics in areas such as Myeloid, Cancer research and Apoptosis.
His Transplantation research integrates issues from Andrology, Immunosuppression, Tolerance induction and Immune reactivity.
His study in Antigen-presenting cell is interdisciplinary in nature, drawing from both Transplant rejection and Antigen.
His most cited work include:
- Tolerogenic dendritic cells and the quest for transplant tolerance. (739 citations)
- Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. (686 citations)
- Immunoregulatory functions of mTOR inhibition (642 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Transplantation, Dendritic cell, T cell and Immune system.
His Immunology study combines topics in areas such as Cytotoxic T cell and Organ transplantation.
His Transplantation research includes themes of Cellular immunity, Antigen, Tolerance induction and Pathology.
His work carried out in the field of Dendritic cell brings together such families of science as CD86, Cytokine, Progenitor cell, MHC class II and Cell biology.
His Cell biology research focuses on In vivo and how it connects with In vitro.
His T cell research is multidisciplinary, incorporating elements of Cancer research, CD8, Molecular biology, CD80 and FOXP3.
He most often published in these fields:
- Immunology (64.03%)
- Transplantation (28.55%)
- Dendritic cell (22.90%)
What were the highlights of his more recent work (between 2012-2021)?
- Immunology (64.03%)
- Transplantation (28.55%)
- T cell (20.65%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, Transplantation, T cell, Cancer research and Immune system.
His Immunology study integrates concerns from other disciplines, such as Ex vivo and Liver transplantation.
His studies deal with areas such as Immunosuppression, Cell therapy, Antigen and Immunotherapy as well as Transplantation.
Angus W. Thomson works mostly in the field of T cell, limiting it down to concerns involving CD8 and, occasionally, CD86.
His research on Cancer research also deals with topics like
- PI3K/AKT/mTOR pathway that intertwine with fields like Kinase,
- mTORC1 that connect with fields like Sirolimus.
Immune system is often connected to Cytokine in his work.
Between 2012 and 2021, his most popular works were:
- Adoptive regulatory T cell therapy protects against cerebral ischemia (173 citations)
- Dendritic cells and macrophages in the kidney: a spectrum of good and evil (112 citations)
- Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. (85 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Internal medicine
- Gene
His primary scientific interests are in Immunology, Transplantation, T cell, Cell biology and Cancer research.
Angus W. Thomson studies Immunology, focusing on CD8 in particular.
He has researched CD8 in several fields, including Cytotoxic T cell, Dendritic cell, Tacrolimus and CD86.
His work deals with themes such as Immunosuppression, PI3K/AKT/mTOR pathway and Immune system, Immune tolerance, which intersect with Transplantation.
Angus W. Thomson has included themes like Major histocompatibility complex, Transplant rejection, Cell therapy and Interleukin 15 in his T cell study.
His research in Cell biology intersects with topics in Adoptive cell transfer, CD80 and PD-L1.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
